Compare VANI & MSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VANI | MSI |
|---|---|---|
| Founded | 1998 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 77.5B |
| IPO Year | 2014 | 1994 |
| Metric | VANI | MSI |
|---|---|---|
| Price | $1.33 | $461.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $3.50 | ★ $505.14 |
| AVG Volume (30 Days) | 220.5K | ★ 881.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 38.14 |
| EPS | N/A | ★ 5.51 |
| Revenue | $4,000,000.00 | ★ $6,380,000,000.00 |
| Revenue This Year | N/A | $9.79 |
| Revenue Next Year | N/A | $5.92 |
| P/E Ratio | ★ N/A | $84.03 |
| Revenue Growth | N/A | ★ 5.66 |
| 52 Week Low | $0.92 | $359.36 |
| 52 Week High | $1.92 | $494.85 |
| Indicator | VANI | MSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 46.46 |
| Support Level | $1.26 | $453.60 |
| Resistance Level | $1.34 | $474.17 |
| Average True Range (ATR) | 0.08 | 8.71 |
| MACD | -0.01 | -4.45 |
| Stochastic Oscillator | 4.67 | 7.52 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment, dispatch software, and other networking capabilities. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.